NeuraLace Announces FDA 510(k) Clearance & U.S. Launch Of Axon Therapy® Peripheral Nerve Stimulation System For Chronic Pain Relief

NeuraLace Medical, Inc., a medical device company focused on improving pain relief among consumers with debilitating chronic pain, announced that it has received FDA 510(k) clearance for Axon Therapy® to non-invasively stimulate peripheral nerves and provide chronic nerve pain relief. Axon Therapy delivers focused magnetic pulses which activate the damaged peripheral nerve axons that are required to provide relief from chronic nerve pain.

The Axon Therapy coil, connected to a compact stimulation module, produces strong magnetic pulses near the injured nerve during the course of the treatment. NeuraLace's patented low frequency waveform leverages the principles of electromagnetic . . .